Emerging Australian biotechnology company Kira Biotech has secured a $20 million investment to progress its development of new therapies targeting difficult-to-treat immune system disorders. …
Latest Video
New Stories
-
Maybe investigate the issue rather than just get rid of it?
June 4, 2020 - - Comment -
Medicines Australia has 'immediate concerns' over 'review and rescind'
June 4, 2020 - - Latest News -
'Project Orbis' review for STA lung cancer therapy
June 4, 2020 - - Latest News -
COVID-19: Investors call for action to protect life sciences
June 4, 2020 - - Latest News -
Chris Bowen slams 'arbitrary deadline' that will 'only worsen' access
June 3, 2020 - - Latest News -
The 'rescind' and 'inactivate' fix to a political problem
June 3, 2020 - - Comment -
PBAC moves to review and 'rescind' recommendations
June 3, 2020 - - Latest News